Hi Mike, I see you like CEGE...I think they are a good value play, according to Yahoo, as of 4/26/00 they have a cash value of ~$17.478/share, but I think as of today it is up to ~$19/share. I notice that whenever ABGX runs CEGE follows in the same direction, with a touch less magnitude, & visa versa. They have a lot of Gene Therapy patents in different types of viral vectors (kind of a shotgun approach, imo)...but I'm not sure any of them are the key (cuz mine is...j/k, okay so I'm biased : ). The thread on SI is pretty informative. ABGX has some good technology, Xeno mouse...which is a method of creating very specific Ab that bind to foreign proteins, to help aid an immune response against a foreign protein, these Ab are humanized...not as immunogenic in humans(as normal Ab from mice are view as foreign to the human immune system & are thus eliminated; instead the human immune system thinks that it created the Ab, so it does not eliminate them before it can bind/label (to) the foreign protein for destruction). Just a little science background on their technology (@ least I think, who knows I could be in left field...so do your own DD >gg<). FWIW...I almost bought some ABGX/CEGE today, but bought more RMBS instead.
Best of Luck,
Where'd He Go? |
